Page last updated: 2024-08-24

triciribine and Myocardial Ischemia

triciribine has been researched along with Myocardial Ischemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, B; Li, Y; Liu, L; Liu, Y; Qi, B; Wang, Q; Wu, Q1
Habeck, K; Iskandar, F; Latsch, K; Mersmann, J; Tran, N; Zacharowski, K; Zimmermann, R1
C Hamdy, R; Chang Chua, C; Chen, Z; Chua, BH; Gao, J; Izumo, S; McMullen, JR; Shioi, T; Wang, H; Xu, X1

Other Studies

3 other study(ies) available for triciribine and Myocardial Ischemia

ArticleYear
Mechanisms underlying protective effects of trimetazidine on endothelial progenitor cells biological functions against H2O2-induced injury: involvement of antioxidation and Akt/eNOS signaling pathways.
    European journal of pharmacology, 2013, May-05, Volume: 707, Issue:1-3

    Topics: Antioxidants; Cardiotonic Agents; Cells, Cultured; Endothelial Cells; Humans; Hydrogen Peroxide; Malondialdehyde; Myocardial Ischemia; Nitric Oxide Synthase Type III; Oxidative Stress; Proto-Oncogene Proteins c-akt; Ribonucleosides; Signal Transduction; Stem Cells; Superoxide Dismutase; Trimetazidine

2013
Akt or phosphoinositide-3-kinase inhibition reverses cardio-protection in Toll-like receptor 2 deficient mice.
    Resuscitation, 2012, Volume: 83, Issue:11

    Topics: Androstadienes; Animals; Male; Mice; Myocardial Ischemia; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Reperfusion Injury; Ribonucleosides; Toll-Like Receptor 2; Wortmannin

2012
Resistin, an adipocytokine, offers protection against acute myocardial infarction.
    Journal of molecular and cellular cardiology, 2007, Volume: 43, Issue:5

    Topics: Adipokines; Androstadienes; Animals; Aorta; Apoptosis; Disease Models, Animal; Endothelium, Vascular; Heart Ventricles; Male; Mice; Mice, Inbred ICR; Muscle, Smooth, Vascular; Myocardial Infarction; Myocardial Ischemia; Resistin; Ribonucleosides; Wortmannin

2007